Seeing Is Believing
LAVA Therapeutics NV's activity chart (see below) currently has 27 price targets and 32 ratings on display.
Analysts average stock forecasts to be materialized ratio is 19.43% with an average time for these price targets to be met of 51.22 days.
Most recent stock forecast was given by from HC WAINWRIGHT on 06-Aug-2025. First documented stock forecast 19-Apr-2021.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 31-Mar-2025
$1.24
$-0.5 (-28.74%)
$1.5
1 years 1 months 29 days ago
(06-Aug-2025)
3/10 (30%)
$-0.29 (-18.95%)
91
Buy Since 20-Mar-2024
$1.5
$-0.24 (-13.79%)
$6
1 years 2 months ago
(05-Aug-2025)
1/2 (50%)
$-0.01 (-0.66%)
43
Hold Since 31-Mar-2025
1 years 4 months 20 days ago
(15-May-2025)
2/9 (22.22%)
$4.79 (395.87%)
72
Hold Since 31-Mar-2025
$1
$-0.74 (-42.53%)
1 years 6 months 4 days ago
(31-Mar-2025)
0/6 (0%)
$-0.27 (-21.26%)
Buy Since 19-Apr-2021
$19
$17.26 (991.95%)
$22
4 years 5 months 15 days ago
(20-Apr-2022)
0/2 (0%)
$14.82 (354.55%)
What is LVTX (LAVA Therapeutics NV) average time for price targets to be met?
Which analyst most recently updated their price target on LVTX (LAVA Therapeutics NV)?
Which analyst has the most public recommendations on LVTX (LAVA Therapeutics NV)?
Which analyst is the currently most bullish on LVTX (LAVA Therapeutics NV)?
Which analyst is the currently most reserved on LVTX (LAVA Therapeutics NV)?